Standout Papers

Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving s... 2015 2026 2018 2022 474
  1. Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib (2015)
    John C. Byrd, Richard R. Furman et al. Blood

Immediate Impact

3 from Science/Nature 67 standout
Sub-graph 1 of 23

Citing Papers

Remibrutinib in Chronic Spontaneous Urticaria
2025 Standout
Targeting protein–ligand neosurfaces with a generalizable deep learning tool
2025 StandoutNature
2 intermediate papers

Works of Elizabeth Bilotti being referenced

Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib
2015 Standout

Author Peers

Author Last Decade Papers Cites
Elizabeth Bilotti 378 231 573 451 29 814
Olga Samoilova 254 199 559 621 20 895
Diane Warren 506 340 507 418 39 974
Małgorzata Wach 212 101 545 429 34 667
Rachel L. Sargent 232 167 462 428 39 836
Domenico Levato 190 301 655 453 29 949
James D’Rozario 252 195 544 386 25 846
Leanne Holes 250 333 786 556 34 896
F Gomis 467 265 467 425 34 952
Thomas E. Lew 204 211 554 414 32 846
A. M. Liberati 193 116 464 352 19 670

All Works

Loading papers...

Rankless by CCL
2026